Autologous stem cell therapy (Proteonomix)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous stem cell therapy (Proteonomix)

Drug Alias NameUMK-121

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionCell replacementsAngiogenesis inducers

TargetsNot applicable

Therapy Area/IndicationsLiver Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesProteonomix Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesProteonomix Inc

Active IndicationsN/A

Inactive IndicationsLiver Failure

ATC CodeN/A